SMARCA4 and neoplasm: For SMARCA4 different studies show inconsistent results, some state that an increased expression is associated with an advanced stage or poor prognosis,18, 19 while others indicate a tumor‐suppressor function of SMARCA4 with loss‐of‐function mutations being common in cancer.2, 3